Retractable Technologies (RVP) Stock Price

Retractable Technologies Price

NYSE AMEX·CLOSED
0.58
​
Market closed

Over the last 19 years Retractable Technologies grew revenue by 2.2% annually, reaching 38.27 M USD. Earnings per share have grown at 4.5% per year over the last 12 years. For Retractable Technologies, the net margin of -32.8% is down versus 29.8% a few years ago. At today's price the dividend yield works out to roughly 21.55%. The payout ratio is around 83% of earnings.

Retractable Technologies stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Retractable Technologies business model & stock analysis

Retractable Technologies Inc. is a company based in Little Elm, Texas, specializing in the design, manufacturing, and distribution of healthcare safety products. The company was founded in 1994 by Thomas J. Shaw and has played an important role in the field of medical safety technology. The company's business model is simple but effective. It produces and sells safety-related medical products that are crucial for both patients and healthcare professionals. Retractable Technologies Inc. has a variety of patented products in its portfolio to meet the needs of individuals and the healthcare industry as a whole. its comprehensive product range includes safety scalpels, IV catheters, syringes, blood collection lancets, and many other high-quality products. The history of Retractable Technologies Inc. begins with the development of the VanishPoint safety syringe in 1993 by founder Thomas J. Shaw. Unlike traditional syringes, the VanishPoint model has an automatic protective mechanism that retracts the needle inward after use, significantly reducing the risk of needlestick injuries. The product quickly became the company's best-selling product. Over the years, Retractable Technologies Inc. has continuously expanded and improved its product range, focusing on design and innovation to meet the needs of its customers and the healthcare sector as a whole. The company is divided into various segments, all aimed at improving the safety of patients and healthcare professionals. There is the safety scalpel segment, which began in 1999 with the introduction of the safety lancet line in collaboration with the American Diabetes Association. The goal was to develop a painless blood glucose test with previously unmatched safety in the handling of blood collection lancets and personalized drop protection devices. Another important segment of Retractable Technologies Inc. is the syringe category. The focus here is on reducing needlestick injuries and infections when using syringes. The patented safety mechanisms allow doctors, nurses, and other medical personnel to safely operate syringes. These products are available in various sizes to meet the requirements of infants to adults. The IV catheter category is also well positioned, as Retractable Technologies Inc.'s products reduce the number of peripheral infiltrations and catheter-associated bloodstream infections, reduce damage to blood vessels, and provide personalized safety devices. Finally, there is the tuberculin category, which focuses on measuring skin tests and allergic reactions. The category features products with enhanced safety design and is particularly popular among those who rely on this type of testing. Each patient is different and requires a customized solution to reduce the risk of injuries related to medical products. Retractable Technologies Inc. provides its customers with a high level of safety and convenience through its innovative products. The company has become a market leader in the development and manufacture of safe medical products and is committed to meeting customer needs with effective products. With a strong focus on design and innovation, Retractable Technologies Inc. continues to set the standard for safety products throughout the industry.

Frequently asked questions about Retractable Technologies

Retractable Technologies Inc operates under the business model of manufacturing and marketing safety medical devices. As a company, it specializes in retractable syringes, blood collection devices, and other medical products to prevent accidental needlestick injuries. Retractable Technologies Inc prioritizes safety and aims to provide healthcare professionals with innovative tools that minimize the risk of needle-related injuries. With its extensive product portfolio and focus on safety, Retractable Technologies Inc continues to contribute to the medical industry by promoting a safer and more efficient healthcare environment.

Retractable Technologies Inc is primarily active in the healthcare industry.

The main competitors of Retractable Technologies Inc in the market include Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Cardinal Health Inc., and Terumo Corporation. These companies operate in the medical devices industry and offer various products including safety syringes, IV catheters, and other medical supplies. Retractable Technologies Inc faces competition from these established players in terms of product quality, pricing, market share, and customer reach. However, Retractable Technologies Inc distinguishes itself through its patented retractable needle technology, providing enhanced safety and usability features for healthcare professionals.

Retractable Technologies Inc, based in Little Elm, Texas, is a leading manufacturer of safety medical devices, specializing in retractable needle technologies. Founded in 1994 by Thomas J. Shaw, the company initially focused on developing and commercializing their patented VanishPoint® blood collection tube holder. This innovative product aimed to minimize the risk of needlestick injuries among healthcare professionals. Over the years, Retractable Technologies Inc has expanded its product portfolio to include a wide range of safety medical devices, including retractable syringes and safety IV catheters. With a strong commitment to patient and healthcare worker safety, Retractable Technologies Inc continues to be a trusted industry leader in the field.

Retractable Technologies Inc has achieved significant milestones throughout its history. Some noteworthy achievements include the development and patenting of innovative safety medical products, such as the VanishPoint® blood collection tube holder. The company has also obtained various FDA clearances for its devices, positioning it as a leading player in the healthcare industry. Furthermore, Retractable Technologies Inc has successfully established strategic partnerships and collaborations with key market players, enhancing its market presence and expanding its customer base. These milestones demonstrate the company's commitment to creating cutting-edge medical devices and its dedication to improving patient safety.

Retractable Technologies Inc is primarily present in the United States. With headquarters in Little Elm, Texas, the company focuses on the domestic market. Their innovative medical devices, such as safety syringes and blood collection sets, are widely used by healthcare professionals across the country. Retractable Technologies Inc has built a strong presence and reputation within the United States for its cutting-edge products that prioritize safety and ease of use.

Retractable Technologies Inc represents a strong commitment to safety and innovation in the healthcare industry. With a focus on developing safe medical devices, Retractable Technologies is dedicated to preventing needlestick injuries and other related accidents. Their corporate philosophy is centered around providing high-quality, reliable products that enhance patient and healthcare professional safety. By prioritizing research and development, Retractable Technologies continuously strives to improve their products and meet the evolving needs of the healthcare community. Through their dedication to safety and innovation, Retractable Technologies Inc has become a trusted name in the medical device industry.

Converted at the current exchange rate, the Retractable Technologies share trades at 0.52 EUR (0.58 USD).

Retractable Technologies Inc. (RTI) is a leading company in the global production of medical syringes and needles. The US-based company is headquartered in Little Elm, Texas and has been listed on NASDAQ since 1994. RTI manufactures disposable medical syringes and needles that ensure a high level of safety and sterility. The portfolio includes disposable syringes, withdrawal needles, safety needles, and catheters. The company has received several patents for its products, including the attached pull cord that facilitates needle insertion while reducing the oxidation process of syringes. RTI's business model is based on three pillars: production, research, and development of new products. The company focuses on ensuring the highest quality and sterility, as well as creating products that help hospitals and clinics provide safer care for their patients. The core business of RTI is the production of medical syringes and needles. The company has eight production facilities in the US and employs over 700 people worldwide. The production of syringes and needles is a highly technical process that requires the highest quality and precision. Therefore, the company continually invests in state-of-the-art production and quality assurance technology. The second focus of RTI is research and development of new products. The company has a dedicated team of scientists and engineers working on the development of new technologies. An important focus is improving the safety of medical syringes and needles and developing products that make the work of healthcare professionals safer and more effective. RTI is also active in other areas. For example, the company has a subsidiary, Inverness Medical Innovations, which specializes in the production of rapid tests for healthcare. The rapid tests allow for quick diagnosis of diseases and effective treatment. In summary, RTI is a leading company in the production of medical syringes and needles with a clear focus on quality, safety, and innovation. The company has a strong presence in the US and exports its products worldwide. The company's research and development department is dedicated to developing new products and technologies that improve the lives of medical professionals and make patient care safer.

The revenue cannot currently be calculated for Retractable Technologies.

The profit cannot currently be calculated for Retractable Technologies.

The P/E ratio cannot be calculated for Retractable Technologies at the moment.

The P/S cannot be calculated for Retractable Technologies currently.

The Eulerpool Quality Score for Retractable Technologies is 1/10.

The ISIN of Retractable Technologies is US76129W1053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Retractable Technologies is 785356. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Retractable Technologies is RVP. The ticker symbol is used to trade Retractable Technologies shares on the stock exchange.

Fair ValueTerminal
0.49 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
190,379.16 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Currency
USD
Initial public offering
May 4, 2001
ISIN
US76129W1053
Cusip
76129W105
Sedol
2754888
Market capitalization
17.37 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.23
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-16.69 %
Last updated Oct 24, 2026, 3:50 AM

Retractable Technologies Ticker

AMEX · RVP

Retractable Technologies FIGI

RVP:US · BBG000D79KB3RVP:UA · BBG000D79KZ7RVP:UC · BBG000D79LK1RVP:UN · BBG000D79ML8RVP:UP · BBG000D79N09RVP:UB · BBG000D79PN9RVP:UT · BBG000D79QL9RVP:UM · BBG000D79QT1RVP:UX · BBG000D79S35RVP:UD · BBG000D79VQ3RVP:UF · BBG000D79XN2RVP:VY · BBG000D7BZH1